China’s HD Biosciences Completes Series A Financing; Led By Lilly, Pfizer And Morningside

SHANGHAI - HD Biosciences has completed its first round of external financing, led by Morningside Group and Lilly Asian Ventures and syndicated with Pfizer Venture Investments, the company announced Aug. 7